帕拉西他摩尔加载剂量在儿童中的使用:一项回顾性研究
Alise D E de Groot1,2, Marijke A J van der Wagt1, Nieko C Punt1
1Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
概括
帕拉塞他充剂很少在儿科医院给予,延迟治疗水平. 实施加重剂量可以显著改善新生儿和儿童的治疗.
科学领域:
- 儿科药理学 儿科药理学
- 临床药房 临床药房
- 美国药物管理局药物管理局.
背景情况:
- 是儿科护理中常见的止痛药和抗炎药.
- 最佳的剂量策略,包括充满剂量,对于实现治疗疗效至关重要.
- 目前在儿科环境中对帕拉西托马尔加重剂量的使用需要评估.
研究的目的:
- 为了评估在儿科医院推的青的加载剂量管理的频率.
- 调查是否需要对青的充电剂量来达到新生儿和儿童的治疗度 (10 mg/L) 的目标.
主要方法:
- 对接受静脉注射或直肠青的新生儿和儿童进行回顾性研究 (2023年1月至2024年1月).
- 评估治疗期与或没有帕拉西他摩尔加重剂量.
- 药物动力学模拟以模拟充满剂量对青的稳定状态度 (Css) 的影响.
主要成果:
- 充满剂量仅在21%的静脉注射和1%的直肠类青治疗中使用.
- 药物动力学模拟表明,加载剂量迅速达到稳定状态度 (Css).
- 如果没有加重剂量,Css被延迟了12小时 (IV) 和18小时 (直肠).
结论:
- 在这个学术儿科医院中,青的充电剂量未得到充分利用.
- 由于没有加重剂量,因此显著延迟了达到治疗性度的青.
- 对儿科患者的青治疗方案的改进是有必要的.
相关概念视频
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
66
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
66
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.7K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.7K
Drug Delivery: Enteral Route
360
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
360
Pharmacovigilance
762
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
762


